Company Filing History:
Years Active: 2025
Title: Zhuming Sun: Innovator in Anti-Cancer Research
Introduction
Zhuming Sun is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biomedical research, particularly in the development of anti-cancer agents. His work focuses on innovative solutions to combat diseases mediated by mixed lineage leukemia 1 (MLL1).
Latest Patents
Zhuming Sun holds a patent for MLL1 inhibitors and anti-cancer agents. The present invention provides a compound of Formula (I) or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof. The variables are defined within the patent documentation. Furthermore, the invention includes pharmaceutical compositions comprising such compounds and methods for using these compounds to treat diseases associated with MLL1.
Career Highlights
Throughout his career, Zhuming Sun has worked with prominent organizations in the biomedical field. He has been associated with China Novartis Institutes for Biomedical Research Co., Ltd. and Novartis AG. His work in these institutions has contributed to advancements in cancer treatment and research.
Collaborations
Zhuming Sun has collaborated with esteemed colleagues, including Zhenting Gao and Haibing Guo. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of cancer therapeutics.
Conclusion
Zhuming Sun is a distinguished inventor whose work in anti-cancer research has the potential to make a significant impact on treatment options for patients. His innovative approach and dedication to biomedical research continue to inspire advancements in the field.